Luiz Carlos Dias

My main lines of research in CIBFar are: Synthesis of compounds for the treatment of Malaria and Chagas Disease in collaboration with the Drugs for Neglected Diseases initiative (DNDi, www.dndi.org) and with the Medicines for Malaria Venture (MMV, www.mmv.org).